Using Cutting Edge Tech, Georgetown Team Proves Pancreatic Cancer TargetCadherin 11 protein (CDH11), Fibrosis, Gastroenterology, Health Technology, Immune System, Medical Journals, Pancreatic Cancer, Survival RatesStephen Byers, Ph.D., associate director and professor of oncology at Georgetown Lombardi, and his team published a paper in the journal Gastroenterology regarding their findings of a novel target for pancreatic cancer therapy. Read more January 19, 2021/by Andrew Humphreys https://www.pharmalive.com/wp-content/uploads/2021/01/Using-Cutting-Edge-Tech-Georgetown-Team-Proves-Pancreatic-Cancer-Target-BioSpace-1-19-21.jpeg 350 625 Andrew Humphreys https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png Andrew Humphreys2021-01-19 16:53:592021-01-19 16:53:59Using Cutting Edge Tech, Georgetown Team Proves Pancreatic Cancer Target